Complyomics

Complyomics Sàrl supports Life-Science companies involved at all stages of drug development to reach their objectives in terms of Quality and Compliance.

Glycocalyx

A discovery & pre-clinical-stage company and a pioneer in the development of transformative pan-cancer therapies that target the tumor microenvironment removing barriers and inducing intra-tumoral immune architecture for effective full-circle immunotherapy.

Boderm Pharmaceutical S.A.

Boderm Pharmaceutical S.A. is a dynamic pharmaceutical company. It engages in the international market of Dermatology in Medicines, Medical Devices, Food Supplements, and Cosmetics.

BioCopy AG

BioCopy delivers new technologies for the development of vaccine precursors.

Expert.ai

Expert.ai delivers cutting edge applications that analyze any documents to drive insights.

Biofi AG

BioFi accelerates biological innovation through first-in-class biomimetic simulation technologies.

FatiAbGen

FatiAbGen is a leading antibody engineering company developing best in class multi-modality antibodies for difficult targets in high unmet need diseases in oncology and immunology.

Skyvor Medical

Our novel digital platform enables NextGen clinical research.

PEN Partnerships

PEN Life Sciences are specialists in creating next-generation business models for life science companies to improve patient outcomes, with a particular focus on the customer and patient journeys.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.